135 related articles for article (PubMed ID: 1648523)
1. Differentiation induction of human promyelocytic leukemia cells by 10-hydroxycamptothecin, a DNA topoisomerase I inhibitor.
Ling YH; Tseng MT; Nelson JA
Differentiation; 1991 Mar; 46(2):135-41. PubMed ID: 1648523
[TBL] [Abstract][Full Text] [Related]
2. DNA topoisomerase I as a site of action for 10-hydroxycamptothecin in human promyelocytic leukemia cells.
Ling YH; Andersson BS; Nelson JA
Cancer Biochem Biophys; 1990 Jan; 11(1):23-30. PubMed ID: 2159843
[TBL] [Abstract][Full Text] [Related]
3. Effect of phorbol ester treatment on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells.
Zwelling LA; Chan D; Hinds M; Mayes J; Silberman LE; Blick M
Cancer Res; 1988 Dec; 48(23):6625-33. PubMed ID: 2846155
[TBL] [Abstract][Full Text] [Related]
4. Effect of DNA topoisomerase I inhibitor, 10-hydroxycamptothecin, on the structure and function of nuclei and nuclear matrix in bladder carcinoma MBT-2 cells.
Ling YH; Perez-Soler R; Tseng MT
Anticancer Res; 1993; 13(5A):1613-7. PubMed ID: 8239542
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of phosphorylation of histone H1 and H3 induced by 10-hydroxycamptothecin, DNA topoisomerase I inhibitor, in murine ascites hepatoma cells.
Ling YH; Xu B
Zhongguo Yao Li Xue Bao; 1993 Nov; 14(6):546-50. PubMed ID: 8010056
[TBL] [Abstract][Full Text] [Related]
6. Homocamptothecin, an E-ring-modified camptothecin analogue, generates new topoisomerase I-mediated DNA breaks.
Bailly C; Lansiaux A; Dassonneville L; Demarquay D; Coulomb H; Huchet M; Lavergne O; Bigg DC
Biochemistry; 1999 Nov; 38(47):15556-63. PubMed ID: 10569939
[TBL] [Abstract][Full Text] [Related]
7. [Preliminary studies of notoginsenoside R1-induced differentiation of HL-60 cell lines in vitro].
Xu L; Wang B; Gao J
Hua Xi Yi Ke Da Xue Xue Bao; 1991 Jun; 22(2):124-7. PubMed ID: 1786946
[TBL] [Abstract][Full Text] [Related]
8. A human small cell lung carcinoma cell line, resistant to 4'-(9-acridinylamino)-methanesulfon-m-anisidide and cross-resistant to camptothecin with a high level of topoisomerase I.
Prost S; Riou G
Biochem Pharmacol; 1994 Aug; 48(5):975-84. PubMed ID: 8093110
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis induced by DNA topoisomerase I and II inhibitors in human leukemic HL-60 cells.
Solary E; Bertrand R; Pommier Y
Leuk Lymphoma; 1994 Sep; 15(1-2):21-32. PubMed ID: 7858500
[TBL] [Abstract][Full Text] [Related]
10. A novel B-ring modified homocamptothecin, 12-Cl-hCPT, showing antiproliferative and topoisomerase I inhibitory activities superior to SN-38.
Bailly C; Laine W; Baldeyrou B; Demarquay D; Huchet M; Coulomb H; Lanco C; Lavergne O; Bigg DC
Anticancer Drug Des; 2001 Feb; 16(1):27-36. PubMed ID: 11762642
[TBL] [Abstract][Full Text] [Related]
11. Activity of a novel camptothecin analogue, homocamptothecin, in camptothecin-resistant cell lines with topoisomerase I alterations.
Urasaki Y; Takebayashi Y; Pommier Y
Cancer Res; 2000 Dec; 60(23):6577-80. PubMed ID: 11118036
[TBL] [Abstract][Full Text] [Related]
12. Altered susceptibility of differentiating HL-60 cells to apoptosis induced by antitumor drugs.
Del Bino G; Li X; Traganos F; Darzynkiewicz Z
Leukemia; 1994 Feb; 8(2):281-8. PubMed ID: 7508535
[TBL] [Abstract][Full Text] [Related]
13. Subcellular redistribution of DNA topoisomerase I in anaplastic astrocytoma cells treated with topotecan.
Danks MK; Garrett KE; Marion RC; Whipple DO
Cancer Res; 1996 Apr; 56(7):1664-73. PubMed ID: 8603418
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis induction and cell cycle perturbation in human hepatoma hep G2 cells by 10-hydroxycamptothecin.
Zhang XW; Qing C; Xu B
Anticancer Drugs; 1999 Jul; 10(6):569-76. PubMed ID: 10885905
[TBL] [Abstract][Full Text] [Related]
15. The interaction between nuclear topoisomerase II activity from human leukemia cells, exogenous DNA, and 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) or 4-(4,6-O-ethylidene-beta-D-glucopyranoside) (VP-16) indicates the sensitivity of the cells to the drugs.
Estey EH; Silberman L; Beran M; Andersson BS; Zwelling LA
Biochem Biophys Res Commun; 1987 Apr; 144(2):787-93. PubMed ID: 3034264
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors.
Bertrand R; Solary E; Jenkins J; Pommier Y
Exp Cell Res; 1993 Aug; 207(2):388-97. PubMed ID: 7688316
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of p21WAF1/CIP1 in human breast cancer cell lines MCF-7 and MDA-MB-468 undergoing apoptosis induced by natural product anticancer drugs 10-hydroxycamptothecin and camptothecin through p53-dependent and independent pathways.
Liu W; Zhang R
Int J Oncol; 1998 Apr; 12(4):793-804. PubMed ID: 9499438
[TBL] [Abstract][Full Text] [Related]
18. Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors.
Solary E; Bertrand R; Kohn KW; Pommier Y
Blood; 1993 Mar; 81(5):1359-68. PubMed ID: 8382972
[TBL] [Abstract][Full Text] [Related]
19. DNA damage and cell killing by camptothecin and its derivative in human leukemia HL-60 cells.
Yoshida A; Ueda T; Wano Y; Nakamura T
Jpn J Cancer Res; 1993 May; 84(5):566-73. PubMed ID: 8391526
[TBL] [Abstract][Full Text] [Related]
20. Antisense protein kinase A RIalpha acts synergistically with hydroxycamptothecin to inhibit growth and induce apoptosis in human cancer cells: molecular basis for combinatorial therapy.
Cho YS; Cho-Chung YS
Clin Cancer Res; 2003 Mar; 9(3):1171-8. PubMed ID: 12631623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
